We use cookies to enhance your experience. By continuing to browse this site you agree to our use of cookies. More info.

The gold standard for the diagnosis of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is currently based on detection using quantitative reverse-transcription polymerase chain reaction (RT-qPCR) in nasopharyngeal swabs collected from individuals. There are multiple RT-qPCR methods that have been proven very accurate, sensitive, and reliable and nasopharyngeal swabs are optimal for detection of infection especially in the early stages.

However, in the latter stages of the disease, there is a decline in the viral load in the nasopharynx, and the virus often becomes detectable only in specimens taken from bronchoalveolar lavage or sputum. Hence, additional testing strategies are needed to broaden and increase testing opportunities. To overcome these limitations in mass screening for detection of SARS-CoV-2, saliva has been considered as an alternate specimen. While nasopharyngeal swab collection requires trained health care personnel, saliva collection is relatively easier, less invasive, creates less discomfort to the patient, and can even be done through self-collection. Saliva specimens would also be particularly advantageous while testing children.

A team of researchers from various institutes in Switzerland recently sought to develop and evaluate a strategy for saliva sampling that enables easy and safe sampling of virus-containing specimen in adults and children, with the possibility for home collection and straight forward processing in the lab. Their study has been published on the preprint server, medRxiv*.

In their paper, the researchers report the outcome of a head-to-head comparison of SARS-CoV-2 detection in saliva and nasopharyngeal swabs using RT-PCR in 1,187 adults and children at outpatient test centers and an emergency unit.

According to the results, a total of 252 individuals tested positive for SARS-CoV-2 in either nasopharyngeal swab or saliva specimens. SARS-CoV-2 RT PCR results in both the specimens showed a high level of agreement with an overall percent agreement of 98.0%. Despite lower viral loads in saliva specimens, sensitive detection of SARS-CoV-2 was observed in saliva up to a threshold of Ct 33 in the corresponding nasopharyngeal swabs. In patients with Ct over 33 in nasopharyngeal swab, the agreement rate declined, but still was at 55.9%.

Despite lower viral loads in saliva, we observed sensitive detection of SARS-CoV-2 in saliva up to a threshold of Ct 33 in the corresponding NPS (Positive Percent Agreement = 97.7%).”

This large study conducted a parallel analysis of nasopharyngeal swab and saliva specimens, and the results established that saliva is a reliable specimen for SARS-CoV-2 detection. For the researchers, this means it can be added to the diagnostic portfolio to increase testing in a more convenient manner in adults as well as children.

Our study demonstrates an excellent agreement of saliva in the head-to-head comparison with NPS and thus recommends saliva as alternate material for SARS-CoV-2 detection by RT-PCR.”

According to the authors, since the majority of the virus in the saliva is not locally produced and is likely secreted from infected cells in the nasopharynx, it is important to collect the material from the posterior oropharynx. This is also highlighted in the collection protocols in their study.

To summarize, the analysis by the researchers rated saliva as a valid alternate specimen option for SARS-CoV-2 detection using RT-PCR. Saliva collection is non-invasive and hence reduces discomfort to the patient during sample collection. It eliminates the need for trained staff, allows sample collection anywhere, and enables self-collection. More importantly, the results show that using saliva as the test specimen does not require adjustments in the RT-PCR diagnostics tests.

All these benefits, combined with high reliability in SARS-CoV-2 detection, as demonstrated in this head-to-head comparison with nasopharyngeal swabs, highlight the need to increase testing efforts using saliva specimens and monitoring SARS-CoV-2 infection more effectively.

Combined with the high reliability in detecting SARS-CoV-2 infection as demonstrated in our head-to-head comparison with the standard NPS, increasing and facilitating test efforts by monitoring SARS-CoV-2 infection in saliva is rapidly attainable and needs to be considered.”

medRxiv publishes preliminary scientific reports that are not peer-reviewed and, therefore, should not be regarded as conclusive, guide clinical practice/health-related behavior, or treated as established information.

Posted in: Medical Science News | Medical Research News | Disease/Infection News

Tags: Children, Coronavirus, Coronavirus Disease COVID-19, CT, Diagnostic, Diagnostics, Health Care, Nasopharyngeal, Polymerase, Polymerase Chain Reaction, Respiratory, SARS-CoV-2, Severe Acute Respiratory, Severe Acute Respiratory Syndrome, Syndrome, Transcription, Virus

Susha has a Bachelor of Science (B.Sc.) degree in Chemistry and Master of Science (M.Sc) degree in Biochemistry from the University of Calicut, India. She always had a keen interest in medical and health science. As part of her masters degree, she specialized in Biochemistry, with an emphasis on Microbiology, Physiology, Biotechnology, and Nutrition. In her spare time, she loves to cook up a storm in the kitchen with her super-messy baking experiments.

Please use one of the following formats to cite this article in your essay, paper or report:

Cheriyedath, Susha. (2020, December 08). Saliva samples may be reliable alternative to nasal swabs for SARS-CoV-2 testing. News-Medical. Retrieved on August 08, 2022 from https://www.news-medical.net/news/20201208/Saliva-samples-may-be-a-reliable-alternative-to-nasal-swabs-for-SARS-CoV-2-testing.aspx.

Cheriyedath, Susha. "Saliva samples may be reliable alternative to nasal swabs for SARS-CoV-2 testing". News-Medical. 08 August 2022. <https://www.news-medical.net/news/20201208/Saliva-samples-may-be-a-reliable-alternative-to-nasal-swabs-for-SARS-CoV-2-testing.aspx>.

Cheriyedath, Susha. "Saliva samples may be reliable alternative to nasal swabs for SARS-CoV-2 testing". News-Medical. https://www.news-medical.net/news/20201208/Saliva-samples-may-be-a-reliable-alternative-to-nasal-swabs-for-SARS-CoV-2-testing.aspx. (accessed August 08, 2022).

Cheriyedath, Susha. 2020. Saliva samples may be reliable alternative to nasal swabs for SARS-CoV-2 testing. News-Medical, viewed 08 August 2022, https://www.news-medical.net/news/20201208/Saliva-samples-may-be-a-reliable-alternative-to-nasal-swabs-for-SARS-CoV-2-testing.aspx.

In this interview, we speak to Charles Wells from Gates MRI about their current research into tuberculosis (TB) as well as the recent updated guidelines for TB care.

In this interview, we speak to Dr. Jordan Green about his latest research partnership with Modality.AI that investigated whether an app could be used to effectively diagnose speech decline due to ALS.

In this interview, we speak to Tom Kostrzewski, VP of Science and Technology at CN Bio, about their organ-on-a-chip product and the future of drug discovery.

News-Medical.Net provides this medical information service in accordance with these terms and conditions. Please note that medical information found on this website is designed to support, not to replace the relationship between patient and physician/doctor and the medical advice they may provide.

This site complies with the HONcode standard for trustworthy health information: verify here.

News-Medical.net - An AZoNetwork Site

Owned and operated by AZoNetwork, © 2000-2022